These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 11427819)

  • 1. [Mechanism of action and therapeutic uses of botulinum and tetanus neurotoxins].
    Popoff MR; Marvaud JC; Raffestin S
    Ann Pharm Fr; 2001 May; 59(3):176-90. PubMed ID: 11427819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular mechanism of action of tetanus toxin and botulinum neurotoxins].
    Poulain B
    Pathol Biol (Paris); 1994 Feb; 42(2):173-82. PubMed ID: 7916455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum and tetanus neurotoxins: structure, function and therapeutic utility.
    Turton K; Chaddock JA; Acharya KR
    Trends Biochem Sci; 2002 Nov; 27(11):552-8. PubMed ID: 12417130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The structure and mechanism of action of clostridial neurotoxins].
    Parasion S; Bartoszcze M; Gryko R
    Przegl Epidemiol; 2007; 61(3):519-27. PubMed ID: 18069389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetanus and botulinum neurotoxins: mechanism of action and therapeutic uses.
    Pellizzari R; Rossetto O; Schiavo G; Montecucco C
    Philos Trans R Soc Lond B Biol Sci; 1999 Feb; 354(1381):259-68. PubMed ID: 10212474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of pharmacologic antagonists to deduce commonalities of biologic activity among clostridial neurotoxins.
    Simpson LL
    J Pharmacol Exp Ther; 1988 Jun; 245(3):867-72. PubMed ID: 2455038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Botulism: the agent, mode of action of the botulinum neurotoxins, forms of acquisition, treatment and prevention].
    Marvaud JC; Raffestin S; Popoff MR
    C R Biol; 2002 Aug; 325(8):863-78; discussion 879-83. PubMed ID: 12391898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellularly injected tetanus toxin inhibits exocytosis in bovine adrenal chromaffin cells.
    Penner R; Neher E; Dreyer F
    Nature; 1986 Nov 6-12; 324(6092):76-8. PubMed ID: 3785374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clostridial neurotoxins: from toxins to therapeutic tools?
    Niemann H; Binz T; Grebenstein O; Kurazono H; Thierer J; Mochida S; Poulain B; Tauc L
    Behring Inst Mitt; 1991 Jul; (89):153-62. PubMed ID: 1930094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxins: mechanisms of action, antinociception and clinical applications.
    Wheeler A; Smith HS
    Toxicology; 2013 Apr; 306():124-46. PubMed ID: 23435179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanisms of action of botulinum toxins and neurotoxins].
    Poulain B; Lonchamp E; Jover E; Popoff MR; Molgó J
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S73-6. PubMed ID: 19576489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xeomin: an innovative new botulinum toxin type A.
    Frevert J
    Eur J Neurol; 2009 Dec; 16 Suppl 2():11-3. PubMed ID: 20002741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of neurotransmitter release by botulinum neurotoxins and tetanus toxin at Aplysia synapses: role of the constituent chains.
    Poulain B; Mochida S; Wadsworth JD; Weller U; Habermann E; Dolly JO; Tauc L
    J Physiol (Paris); 1990; 84(4):247-61. PubMed ID: 1981913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Action mechanisms of botulinum neurotoxins and tetanus neurotoxins].
    Deloye F; Doussau F; Poulain B
    C R Seances Soc Biol Fil; 1997; 191(3):433-50. PubMed ID: 9295967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell entry strategy of clostridial neurotoxins.
    Binz T; Rummel A
    J Neurochem; 2009 Jun; 109(6):1584-95. PubMed ID: 19457120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered toxins: new therapeutics.
    Foster KA
    Toxicon; 2009 Oct; 54(5):587-92. PubMed ID: 19264086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The current use of botulinum toxin.
    Mahant N; Clouston PD; Lorentz IT
    J Clin Neurosci; 2000 Sep; 7(5):389-94. PubMed ID: 10942658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clues to the multi-phasic inhibitory action of botulinum neurotoxins on release of transmitters.
    Dolly JO; Ashton AC; McInnes C; Wadsworth JD; Poulain B; Tauc L; Shone CC; Melling J
    J Physiol (Paris); 1990; 84(3):237-46. PubMed ID: 1963641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum neurotoxin: the ugly duckling.
    Koussoulakos S
    Eur Neurol; 2009; 61(6):331-42. PubMed ID: 19365125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial neurotoxins--a thousand years later.
    Linial M
    Isr J Med Sci; 1995 Oct; 31(10):591-5. PubMed ID: 7591680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.